Showing results (51-60 of 365) with videos related to
Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?C L Loprinzi, P M Ravdin, M de Laurentiis, et al.The Journal of Clinical Investigation|December 21, 2013
The search for treatments to reduce chemotherapy-induced peripheral neuropathyDeirdre R Pachman, Charles L Loprinzi, Axel Grothey, et al.Cureus|August 5, 2017
Scrambler Therapy for the Treatment of Chronic Post-Mastectomy Pain (cPMP)Thomas Smith, Andrea L Cheville, Charles L Loprinzi, et al.BMJ Supportive & Palliative Care|November 1, 2018
Rose geranium in sesame oil nasal spray: a treatment for nasal vestibulitis?Elizabeth J Cathcart-Rake, Deanne Smith, David Zahrieh, et al.Obesity Facts|July 17, 2012
Parenting practices as mediators of child physical activity and weight statusPaul D Loprinzi, Bradley J Cardinal, Kristina L Loprinzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and painDeirdre R Pachman, Debra L Barton, Keith M Swetz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
Inhibition of phorbol ester--induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studiesC L Loprinzi, A K Verma, R K Boutwell, et al.The Journal of Community and Supportive Oncology|May 7, 2016
Olanzapine versus fosaprepitant for the prevention of concurrent chemotherapy radiotherapy-induced nausea and vomitingRudolph M Navari, Cindy K Nagy, Jennifer Le-Rademacher, et al.Mayo Clinic Proceedings|November 21, 2002
Pathophysiology and treatment of hot flashesTait D Shanafelt, Debra L Barton, Alex A Adjei, et al.Cancer|December 15, 1988
A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanomaE T Creagan, C L Loprinzi, D L Ahmann, et al.Pageof 37